Gemini PharmChem

Founded in Mannheim, Germany, Gemini PharmChem (part of the Synbias Pharma Group) develops and manufactures highly potent Active Pharmaceutical Ingredients (APIs) for oncology. The company's portfolio includes anthracyclines and nucleoside analogs such as Doxorubicin HCl, Epirubicin HCl, Idarubicin HCl, Valrubicin, Pirarubicin, and Nelarabine. Their APIs exceed pharmacopoeial standards, with impurity limits as low as 0.10% compared to the European Pharmacopoeia's 0.5%. The site has passed 19 inspections by agencies including the US FDA and German authorities. Products are shipped to customers in 21 countries.